Structure Therapeutics (NASDAQ:GPCR) just reported results for the second quarter of 2024.
- Structure Therapeutics reported earnings per share of -18 cents. This was above the analyst estimate for EPS of -23 cents.
- The company did not report any revenue for the quarter.